Italians find one of engines behind pancreatic cancer
(ANSA) – ROME, NOV 1 – A team of Italian scientists have found one of the engines that drive cancer of the pancreas, one of […]
Italians find one of engines behind pancreatic cancer Read More »
New blood test for 50 types of cancer could detect disease at early stages before symptoms
Cancer often takes its time before it triggers first warning signs, meaning it’s often picked up at a later stage. However, the sooner the cancer
First person in the world to get the breast cancer vaccine says it’s changed her life. Here’s how it works.
Finding a cure for cancer has been the holy grail in medicine for years. With the exception of the only two cancer vaccines currently available
Why CAR-T cell therapy is the cancer killer the world needs now
Austin Wolcott was 18 years old and pretty sure he wouldn’t survive the year. It was the summer of 2020, and Wolcott had been given
Why CAR-T cell therapy is the cancer killer the world needs now Read More »
Scientists developing implant to cure cancer in just 60 days — with goal to slash death rates by 50%
There’ll be an app for that. Curing cancer could soon be as easy as a few taps on your mobile, according to a team of scientists
Ascletis enrolls all patients in trial of glioblastoma therapy
Chinese biotechnology company Ascletis Pharma has enrolled all 120 patients in its Phase III clinical trial of ASC40 in combination with bevacizumab for the treatment
Ascletis enrolls all patients in trial of glioblastoma therapy Read More »
Synthekine doses first subject in Phase Ib of solid tumours trial
Synthekine has dosed the first subject in the Phase Ib portion of a clinical trial of STK-012 to treat solid tumours. The open-label, non-randomised, multicentre, dose expansion
Synthekine doses first subject in Phase Ib of solid tumours trial Read More »
Verismo doses first patient in advanced cancers therapy trial
Verismo Therapeutics has dosed the first patient in the first-in-human Phase I STAR-101 clinical trial of SynKIR-110 to treat advanced cancers. The dose-escalation, open-label, multicentre
Verismo doses first patient in advanced cancers therapy trial Read More »
Cancer patients who fail to respond to chemotherapy offered new hope
By Stephen Beech via SWNS Cancer patients who fail to respond to chemotherapy have been offered fresh hope. British scientists have discovered two new genes that
Cancer patients who fail to respond to chemotherapy offered new hope Read More »
Dopamine-producing cells implanted in human brains found to fight Parkinson’s
Abiotech company that implanted dopamine-producing cells into human brains to fight Parkinson’s disease has made a potentially huge breakthrough. MIT announced that BlueRock Therapeutics, a subsidy
Dopamine-producing cells implanted in human brains found to fight Parkinson’s Read More »
Carisma Therapeutics reports results from cancer therapy trial
US-based biotechnology company Carisma Therapeutics has reported findings from a Phase I clinical trial of CT-0508 for the treatment of advanced/metastatic human epidermal growth factor
Carisma Therapeutics reports results from cancer therapy trial Read More »
ABM Therapeutics doses first patient in brain tumour drug trial
Biotechnology company ABM Therapeutics has dosed the first patient in its Phase I study to evaluate ABM-1310 in patients with relapsed and drug-resistant primary malignant
ABM Therapeutics doses first patient in brain tumour drug trial Read More »